Christi Grimm interview, Crisis at HHS, Medicare rates

The American Medical Association (AMA) has recently sent a letter to UnitedHealth, urging the insurance company to hold off on collecting payments until physicians determine it is the appropriate time. The AMA emphasized that physicians have relied on UnitedHealth’s statements and need to have the final say on when payment should be made.

In 2021, Medicare Advantage insurers reportedly made $33 billion by adding diagnosis codes to patients’ medical records. Shockingly, UnitedHealth alone accounted for 42% of that total revenue. This significant amount highlights the reliance on diagnosis codes for financial gain within the healthcare industry.

In a related development, Republicans who have traditionally supported Medicare Advantage are now calling for reforms to the program. Rep. Mike Kennedy of Utah, a family medicine doctor, shared his frustration with UnitedHealth’s HouseCalls programs, stating that he reached a point where he would simply shred the reports without even opening them.

Meanwhile, in Arkansas, lawmakers are pushing to prohibit pharmacy benefit managers from owning mail-order or retail pharmacies. This move aims to address potential conflicts of interest and ensure fair practices within the pharmaceutical industry.

On a different note, employee-led lawsuits seeking to hold employers accountable for inflated drug spending have faced challenges in court. Attorneys representing these employees are adjusting their arguments to address judges’ concerns and improve their chances of success.

In light of these developments, the AMA’s call for UnitedHealth to delay payment collection reflects a broader push for transparency and fairness in healthcare practices. As the industry continues to evolve, stakeholders are navigating complex issues related to billing, diagnosis coding, and pharmaceutical practices to ensure the best outcomes for patients and providers.